Concepedia

Judit Harsányi

JH

Statistics

Publications

8

Citations

634

H-Index

8

Active since

2004

Affiliations

Gedeon Richter (Hungary)(Current)

Allergan (United States)

Innsbruck Medical University

Judit Harsányi is an author at Gedeon Richter (Hungary) specializing in psychopharmacology, psychiatry, and antipsychotic pharmacotherapy.

Publications per year

2004–2025

8

Publications

8

Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial

György Németh, I. Laszlovszky, Pál Czobor et al. · The Lancet · 2017 · 352 citations

, , +14

The efficacy of cariprazine in negative symptoms of schizophrenia: Post hoc analyses of PANSS individual items and PANSS-derived factors

Wolfgang Fleischhacker, Silvana Galderisi, I. Laszlovszky et al. · European Psychiatry · 2019 · 116 citations · Full text

, , +16

Linking PANSS negative symptom scores with the Clinical Global Impressions Scale: understanding negative symptom scores in schizophrenia

Stefan Leucht, Ágota Barabássy, I. Laszlovszky et al. · Neuropsychopharmacology · 2019 · 52 citations · Full text

, , +17

Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Willie Earley, Hua Guo, György Németh et al. · Psychopharmacology Bulletin · 2025 · 42 citations · Full text

, , +17

Cariprazine Safety in Adolescents and the Elderly: Analyses of Clinical Study Data

B. Szatmári, Ágota Barabássy, Judit Harsányi et al. · Frontiers in Psychiatry · 2020 · 24 citations · Full text

, , +17

1–5 of 8